Cover Image
市場調查報告書

全球血糖監測系統市場

Blood Glucose Monitoring (BGM) Devices

出版商 Global Industry Analysts, Inc. 商品編碼 225270
出版日期 內容資訊 英文 358 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球血糖監測系統市場 Blood Glucose Monitoring (BGM) Devices
出版日期: 2015年02月01日 內容資訊: 英文 358 Pages
簡介

本報告提供全球血糖監測系統 (BGM設備) 市場相關調查分析,提供您包含各產品區隔,地區 (美國,加拿大,日本,歐洲,亞太地區,南美等)之市場實際成果與預測,主要企業簡介等系統性資訊。

第1章 簡介,調查手法,產品定義

第2章 摘要整理

  • 產業概要
    • BGM設備
    • 全球糖尿病的盛行率
    • 全球BGM市場
    • 未來成長產品革新和推動進步
    • BGM產品的需求
    • 不景氣和前途
  • 競爭
    • 全球市場的前4大
    • 現場製藥公司的競爭
    • 低價格高品質的產品
    • 配合地區性需求
    • 準確度的容許範圍
  • 市場趨勢·問題點·推動因素
    • 全球糖尿病的盛行率之流行本質
    • 青年人的第一型·第二型糖尿病發病率的上升
    • 高齡化人口導致的糖尿病盛行率
    • 政府配合措施的增加
    • 血糖自我檢測(SMBG)
    • 遙控BGM的重要性劇增
    • 血糖值測試紙
    • 準確度的影響因素
    • 發展中國家的發病率和未診斷人口的增加
  • 技術革新和進步
    • 持續性血糖監測系統 (CGM)
    • CGM市場
    • 競爭情形
    • 有前途的市場
    • 主要課題
  • 糖尿病和BGM設備:概要
    • 所謂糖尿病
    • BGM
    • BGM設備
  • 產品革新/銷售
  • 近來產業活動
  • 全球主要企業
    • Abbott Diabetes Care, Inc. (美國)
    • AgaMatrix, Inc. (美國)
    • 電弧花環 (日本)
    • Arkray USA, Inc. (美國)
    • Bayer Healthcare (美國)
    • Bionime Corp. (台灣)
    • B. Braun Melsungen AG (德國)
    • DexCom, Inc. (美國)
    • LifeScan, Inc. (美國)
    • Medtronic (美國)
    • Nipro Diagnostics, Inc. (美國)
    • Nova Biomedical Corporation (美國)
    • Roche Diagnostics Corp. (美國)
    • Terumo Europe NV (比利時)
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第4章 競爭情形

  • 競爭企業簡介:83公司 (若包含產業部/子公司的話有97家公司)
    • 美國
    • 加拿大
    • 日本
    • 歐洲
    • 亞太地區 (日本以外)
    • 南美
    • 中東

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-3420

This report analyzes the worldwide markets for Blood Glucose Monitoring (BGM) Devices in US$ Million by the following Product Segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 83 companies including many key and niche players such as -

Abbott Diabetes Care, Inc.
AgaMatrix, Inc.
Arkray, Inc.
Bayer Healthcare
Bionime Corp.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Blood Glucose Strips
    • Blood Glucose Meters
    • Lancets

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • BGM Devices: Enabling Efficient Management of the Global Diabetes Epidemic
    • Table 1: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
    • Table 2: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart)
    • Table 3: Top Ten Countries Worldwide with the Highest Number of People (in the Age Group 20-79 Years) with DM (in Millions): 2014E & 2035P (includes corresponding Graph/Chart)
  • Global Diabetes Prevalence: Few Alarming Facts
  • Global Blood Glucose Monitoring (BGM) Market: Growth Drivers in a Nut Shell
  • Future Growth Driven by Product Innovations & Advancements
  • Demand for BGM Products to Witness Varying Patterns in Developed and Developing Markets
  • Recession in Retrospect and the Road Ahead

2. COMPETITION

  • The Big Four in the Global BGM Devices Market
    • Table 4: Leading Players in the Global Blood Glucose Monitoring Devices Market (2014E): Percentage Market Share Breakdown for Abbott, Bayer, LifeScan, Roche, and Others (includes corresponding Graph/Chart)
  • Select Blood Glucose Meters of Leading Manufacturers (2013): Details of Company, Brand Name, Sample Size Required, Time Taken (Seconds), and Special Features
  • Competition with Local Pharma Companies Intensifies in Regional Markets
  • Quality Products at Low Prices: Mantra for Success in the Marketplace
  • Companies Cater to Local Needs to Garner Share in Regional Markets
  • Products Fail Revised ISO Accuracy Tolerance Requirements: A Cause for Concern?
  • Accuracy Tolerance Stipulation Changes to ISO 151971 in 2013 Over 2003 Version

3. MARKET TRENDS, ISSUES AND DRIVERS

  • Epidemic Nature of Global Diabetes Prevalence: A Strong Growth Driver
  • A "Silent Killer" in Both Developed as well as Developing Nations
    • Table 5: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
    • Table 6: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
    • Table 7: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
    • Table 8: Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 9: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
    • Table 10: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 11: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
  • Rising Incidence of Type 1 & Type 2 Diabetes in Children and Young People
  • Diabetes Prevalence Buoyed by Burgeoning Aging Populace
    • Table 12: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
    • Table 13: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 14: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
    • Table 15: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 16: Aging Population by Age Group in More Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 17: Aging Population by Age Group in Less Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 18: Aging Population by Age Group in Least Developed Countries (1975-2050) (includes corresponding Graph/Chart)
  • Targeted Screening of Aging Population Vital to Stem Diabetes Epidemic
  • Increasing Government Efforts for Better DM Management Bodes Well for the Market
  • Self-Monitoring of Blood Glucose (SMBG) Remains a Viable Option
  • After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move
    • Strong Smartphone Sales: A Major Opportunity Indicator for Mobile-Based BGM Devices
    • Table 19: Global Smartphones Sales in Million Units: 2011, 2013, 2015 & 2018 (includes corresponding Graph/Chart)
    • Table 20: Smartphone Penetration Worldwide for Major Countries (as a Percentage of Mobile Phone Users): 2014 (includes corresponding Graph/Chart)
    • Table 21: Smartphone Penetration Worldwide (as a Percentage of Total Population) for Major Countries: 2014E (includes corresponding Graph/Chart)
    • MySugr - Diabetic Management App with Gamification Approach
  • Rising Significance of Remote Blood Glucose Monitoring Augurs Well for Market Expansion
  • Blood Glucose Test Strips: The Largest Segment
  • FDA's New Guidelines for Test Strips
  • Factors Affecting Meter Accuracies & its Impact on BGM
  • New Surveillance Error Grid (SEG) for Monitoring Meter Accuracy
  • Surging Incidence and Undiagnosed Population in Developing Countries Offer Significant Growth Opportunities
    • Table 22: Number of Undiagnosed Cases of Diabetes among Adults in Age Group 20-80 Years by Geographic Region: 2014 (includes corresponding Graph/Chart)
  • China: An Untapped Goldmine for Blood Glucose Monitoring Devices
  • Rising Diabetic Populace Spurs Growth in the Indian BGM Market

4. TECHNOLOGY INNOVATIONS & ADVANCEMENTS

  • Artificial Pancreas Technology: A Potential Game Changer?
  • Non-Invasive Devices: The Next Big Thing in Blood Glucose Monitoring
  • Major Non-Invasive Blood Glucose Monitoring Devices in Research & Development: 2013
  • Select Companies' R&D Initiatives in Non-Invasive Glucose Monitors (2013): Brief Description of Company, Technology, Product, Site, and Key Features
  • Diasensor 1000: The World's First Non-Invasive Glucose Sensor
  • Earlobe Glucose Testing: A New Dimension to Non-Invasive Glucose Monitoring
  • Israeli Bioengineers Develop a New Non-Invasive Glucose Monitoring Device
  • Ultrasound Device to Monitor Glucose Levels
  • Multi-Featured Blood Glucose Monitors
  • Nanotechnology-based Breathalyzer for Glucose Monitoring
  • Mobile Prescription Therapies - New Diabetes Management Solutions
  • Dario by LabStyle - A Smartphone Compatible BGM Device
  • Quick LLC to Develop iQuickIt Saliva Analyzer
  • New Bluetooth-based Glucose Meters for Superior Connectivity
  • Blood Glucose Test Strip Advancements Drive down Prices
  • Test Strip Reimbursement Rates in Select Developed Nations: 2013
  • Real World Challenges Confront Non-Invasive & Painless BGM

5. CONTINUOUS GLUCOSE MONITORING SYSTEMS: A MACRO PERSPECTIVE

  • Continuous Glucose Monitoring (CGM) & Conventional Blood Glucose Monitoring (BGM): Comparison of Key Parameters
  • CGM Market Gradually Breaks through Barriers to Adoption
    • Table 23: Penetration Rate (%) of CGM Devices in Type 1 and Type 2 Diabetes Market in the United States: 2013 through 2020 (includes corresponding Graph/Chart)
  • CGMS: Competitive Landscape
    • Table 24: Leading Products/Brands in the Global Continuous Glucose Monitoring Market (2013): Percentage Value Market Share Breakdown for Dexcom G4 Platinum, Dexcom Seven Plus, Free Style Navigator, Guardian Real Time, Minimed Paradigm Revel and Others (includes corresponding Graph/Chart)
  • Medtronic Dominates the Global CGM Devices Market
    • Recent Noteworthy CGM Innovations of Medtronic
      • Medtronic Introduces Medtronic Minimed Duo for Continuous Glucose Monitoring
      • Medtronic Develops Minimed 530G with Enlite
  • CGM Companies Outsmart Each Other with Innovative Marketing Offers
  • Apple and Google Betting on Wearable Continuous Glucose Monitors
  • Researchers at Glucovation to Develop Glucovation SugarSenz CGM Sensor
  • GlySens Focus on Developing Implantable Continuous Glucose Monitor
  • EyeSense to Develop Affordable CGM Device
  • Becton, Dickinson to Develop an Insulin Pump with CGM Sensor
  • Researchers Develop Prototype of Wearable Closed-Loop System
  • Intensive Care Units: A Highly Promising Market for CGMs
  • Key Challenges Hampering Widespread Adoption of CGM Systems

6. DIABETES AND BGM DEVICES: OVERVIEW

  • What is Diabetes?
  • Types of Diabetes
    • Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
    • Type II Diabetes: Non-Insulin Dependent Diabetes Mellitus (NIDDM)
      • NIDDM: Higher Risk of Cardiovascular Disease
    • Gestational Diabetes
    • Impaired Fasting Glycaemia (IFG) & Impaired Glucose Tolerance (IGT)
  • Blood Glucose Monitoring
  • Blood Glucose Monitoring Devices
  • Blood Glucose Meters
    • Blood Glucose Monitoring Meters: A Historical Perspective
    • Types of Blood Glucose Meters
      • All-In-One Blood Glucose Meters
      • Combined Wrist Blood Pressure and Blood Glucose Meters
      • Wrist-Watch Glucose Meters
      • BGMs with In-Built Food Monitoring Feature
      • Continuous Blood Glucose Meters
      • Talking Blood Glucose Meters
      • Painless Blood Glucose Meters
      • Multisite Blood Glucose Meters
      • Plasma Blood Glucose Meters
    • Measurement Units
  • Blood Glucose Strips
  • Lancets

7. PRODUCT INNOVATIONS/INTRODUCTIONS

  • iHealth Introduces iHealth Align, World's Smallest Blood Glucose Monitor
  • Sanofi Introduces MyStar Extra®, a Self-Monitoring Blood Glucose Meter
  • Lifescan Unveils Onetouch Verio Blood Glucose Monitoring System
  • Medtronic Unveils MiniMed® Duo in Europe
  • Glooko Unveils MeterSync Blue Bluetooth Tool
  • UniStrip Introduces GenStrip Generic Test Strip
  • Omron Unveils Advanced Blood Glucose Monitors
  • ARKRAY USA Announces Compatibility of GLUCOCARD® Blood Glucose Meters with Glooko Mobile App
  • Integrity Applications Displays GlucoTrack®Model DF-F Glucose Monitoring Device
  • Omron Introduces Two New Blood Glucose Monitors, HGM111 and HGM112
  • Procaps Launches New GlucoQuick™
  • Bayer HealthCare Pharmaceuticals Unveils XT Glucometer and NEXT Test strips under CONTOUR® Brand
  • GE Healthcare and Bionime Introduce GE100 Blood Glucose Monitoring System
  • Nova Biomedical Unveils Nova Max™ Blood Glucose Monitoring System
  • BEURER Launches Three-in-one Blood Glucose Monitor
  • Bayer Diabetes Care to Launch Glucometer
  • Cambridge Consultants Design Eco-friendly Blood Glucose Monitor
  • ARKRAY Unveils Audio-Enabled Blood Glucose Monitoring System
  • Sanofi Introduces iBGStar iPhone Blood Glucose Meter in Various Countries
  • Abbott Introduces FreeStyle InsuLinx in Canada
  • Eidia to Introduce LIFE CHECK
  • Telcare Displays Cellular Blood Glucose Meter at AADE

8. RECENT INDUSTRY ACTIVITY

  • Medtronic Takes over Covidien
  • Integrity Applications Inks Distribution Agreements for GlucoTrack® Model DF-F
  • Integrity Applications Inks Distribution Agreement for GlucoTrack® Model DF-F with Felkasta JSC
  • Integrity Applications Obtains CE Mark Approval for GlucoTrack® DF-F
  • Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F in Turkey
  • Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F in New Zealand and Australia
  • Philosys Receives FDA Approval for GMATE® SMART
  • Abbott Obtains CE Mark for FreeStyle® Libre
  • Integrity Applications Inks Manufacturing Agreement with Wistron
  • Bionime Inks Subscription Agreement and Strategic Cooperation Structure Agreement with Sannuo
  • Dexcom Receives FDA Approval for Dexcom G4® PLATINUM Software
  • Dexcom Receives FDA Approval for Dexcom SHARE™
  • Dexcom Receives FDA Approval for Dexcom G4® PLATINUM
  • Nova StatStrip Glucose Hospital Meter System Obtains FDA Clearance
  • Animas Corporation Obtains FDA Approval for Animus Vibe Insulin Pump
  • Nipro Receives FDA Approval for TRUE METRIX™ and TRUE METRIX™ PRO
  • Abbott Recalls FreeStyle Flash® BGM
  • Abbott Recalls FreeStyle InsuLinx® BGMS
  • LifeScan Initiates Recall and Replacement of OneTouch® Verio®IQ BGMs
  • Lifescan Obtains FDA Approval for OneTouch VerioSync
  • Telcare BGM® Receives Clearance to Operate on Verizon Network
  • LabStyle Innovations Inks with InnoMed to Distribute Dario™
  • Integrity Applications Obtains CE Mark Approval for GlucoTrack® Model DF-F Glucose Monitoring Device
  • Philosys Obtains FDA Approval for Gmate® VOICE BGM
  • Abbott Obtains CE Mark for Ketone Monitoring System™ and FreeStyle Optium Neo Blood Glucose
  • Abbott Obtains FDA Approval for β-Ketone Monitoring System™ and FreeStyle Precision Pro Blood Glucose
  • ARKRAY Enters Partnership with Glooko
  • Tandem Expands Development and Commercialization Agreement with Dexcom
  • GE Healthcare Signs Licensing Agreement with Bionime
  • Modz Inks Agreement with Novo Nordisk
  • Merck Serono Inks Distribution Deal with Mendor
  • Abbott Renews Non-Exclusive Agreement with INSULET
  • Pepex Biomedical Inks Manufacturing Agreement with Tech Group
  • Pharmaco Bags Exclusive Distribution Rights for CareSens Blood Glucose Meters
  • Roche Obtains FDA Approval for ACCU-CHEK Inform II System
  • Dexcom Obtains USFDA Approval and CE Mark for Dexcom G4™ PLATINUM CGMS
  • Abbott Obtains FDA Approval for FreeStyle InsuLinx BGM System
  • StatStrip™ Glucose Monitor from Nova Receives FDA Approval for Neonatal Testing
  • Philosys Obtains CE Mark for its Gmate® SMART BGMS
  • Roche Obtains FDA Approval for Accu-Chek Combo System

9. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Diabetes Care, Inc. (US)
  • AgaMatrix, Inc. (US)
  • Arkray, Inc. (Japan)
  • Arkray USA, Inc. (US)
  • Bayer Healthcare (US)
  • Bionime Corp. (Taiwan)
  • B. Braun Melsungen AG (Germany)
  • DexCom, Inc. (US)
  • LifeScan, Inc. (US)
  • Medtronic (US)
  • Nipro Diagnostics, Inc. (US)
  • Nova Biomedical Corporation (US)
  • Roche Diagnostics Corp. (US)
  • Terumo Europe NV (Belgium)

10. GLOBAL MARKET PERSPECTIVE

    • Table 25: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America And Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 27: World 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • Blood Glucose Monitoring Devices by Product Segment
    • Table 28: World Recent Past, Current & Future Analysis for Blood Glucose Strips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Blood Glucose Strips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 30: World 14-Year Perspective for Blood Glucose Strips by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Blood Glucose Meters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 33: World 14-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Lancets by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 36: World 14-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • Table 37: Leading 10 States in the US with the Highest Rate (%) of Type 2 Diabetes: 2013 (includes corresponding Graph/Chart)
    • Table 38: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
      • Diabetes in America: Fast Facts
    • Growth Drivers for BGM Devices Market in a Nut Shell
    • Blood Glucose Monitoring Meters and Strips Sales Dip during Recession
    • Technologic Innovations Fuel US SMBG Market
    • Accuracy: A Major Cause of Concern Plaguing BGM Systems
    • Drugstores Benefit from the Diabetic Care Category
    • Competitive Landscape
    • Table 39: Leading Brands in the US Glucose Test Kits Market (2013): Percentage Breakdown of Value Market Share for Accu Chek Aviva Compact, Accu Chek Aviva Plus, Ascensia Contour, Freestyle Lite, Lifescan One Touch Ultra, and Others (includes corresponding Graph/Chart)
      • Leading BGM Meters in the United States: Brief Description of Manufacturer, Brand, Sample Size and Key Features
      • Manufactures under Pressure to Reduce Prices of Strips
      • Other Challenges Facing Market Participants
    • Regulatory Scenario
      • FDA's Proposal to Improve Blood Glucose Meter Accuracy in Critical Care Units Gathers Criticism
      • Regulations on Lancet Needles to be made More Stringent by FDA
      • TGC Protocols: A Key Driver for Point of Care BGM Market
    • Table 40: US Blood Glucose Strips Market (2014E): Percentage Share Breakdown of Dollar Sales for SMBG Strips and POC Glucose Strips (includes corresponding Graph/Chart)
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 41: US Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 42: US Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 43: US 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 44: Canadian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: Canadian Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 46: Canadian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Japan: A Leading Medical Device Exporting Nation
    • Product Launch
    • Arkray, Inc. - A Key Japanese Player
  • B. Market Analytics
    • Table 47: Japanese Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 48: Japanese Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 49: Japanese 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Scenario
    • Prevalence of Diabetes in Europe: Aging Population Dominate
    • Table 50: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
    • Obesity: A Major Cause of Diabetes in Europe
    • Diabetes Care in Europe Riddled with Challenges
    • St. Vincent Declaration: A Step in the Right Direction
  • B. Market Analytics
    • Table 51: European Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 52: European Historic Review for Blood Glucose Monitoring Devices by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 53: European 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 54: European Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 55: European Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 56: European 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 57: French Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 58: French Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 59: French 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • B. Braun Melsungen Ag - A Key German Player
  • B. Market Analytics
    • Table 60: German Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 61: German Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 62: German 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 63: Italian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 64: Italian Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 65: Italian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Self-Monitoring Blood Glucose Meters Gain Popularity
    • Five Smallest Blood Glucose Meters in the UK: Brief Description
    • Product Launches
  • B. Market Analytics
    • Table 66: UK Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 67: UK Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 68: UK 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 69: Spanish Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 70: Spanish Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 71: Spanish 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 72: Russian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 73: Russian Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 74: Russian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Terumo Europe Nv - A Key Player
  • B. Market Analytics
    • Table 75: Rest of Europe Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 76: Rest of Europe Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 77: Rest of Europe 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth Opportunities
    • Table 78: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
    • Table 79: Prevalence of Diabetes Mellitus in Western Asia-Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • High Growth on Cards for SMBG Devices
    • Asia Suffers from Lack of Focus on Diabetes Care
    • Healthcare Societies and Associations Spread Awareness of Diabetes
    • Western Pacific Declaration on Diabetes
    • Competitive Landscape
    • Distribution Scenario
  • B. Market Analytics
    • Table 80: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Asia-Pacific Historic Review for Blood Glucose Monitoring Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 82: Asia-Pacific 14-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for China, India, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 85: Asia-Pacific 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Current and Future Analysis
    • China: A Market with Huge Untapped Potential for BGM Devices
    • Competitive Landscape
  • B. Market Analytics
    • Table 86: Chinese Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Chinese Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 88: Chinese 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Outlook
    • Diabetic Epidemic in the Country Spurs Market Growth
    • Market Restraints
    • Competitive Landscape
    • Product Launches
  • B. Market Analytics
    • Table 89: Indian Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Indian Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 91: Indian 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • A Review Of Select Markets
      • Australia: A Growing Market for Blood Glucose Monitoring Devices
      • Hong Kong: Low Awareness Levels Offer Opportunities
      • Malaysia Witness Surge in Chronic Diseases Incidence, including DM
      • Taiwan: SMBG Devices Market on the Rise
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 92: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 93: Rest of Asia-Pacific Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 94: Rest of Asia-Pacific 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
    • Table 95: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
    • National Diabetes Programs
    • Product Launch
  • B. Market Analytics
    • Table 96: Latin American Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 97: Latin American Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 98: Latin American 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current and Future Analysis
    • United Arab Emirates: Rising Diabetic Cases to Propel Market Demand
    • Key Statistics: Diabetes Prevalence in Middle East and African Regions
    • Table 99: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 100: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 101: Rest of World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 102: Rest of World Historic Review for Blood Glucose Monitoring Devices by Product Segment - Blood Glucose Strips, Blood Glucose Meters and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 103: Rest of World 14-Year Perspective for Blood Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters and Lancets Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top